This HEAL Initiative JCOIN grant targets the critical need for improved addiction treatment within the U.S. justice system. Individuals involved with the criminal justice system face elevated risks of opioid use disorder (OUD) and overdose, particularly post-release, due to limited access to Medications for Opioid Use Disorder (MOUD) during incarceration. Many jails currently do not offer MOUD universally. The JCOIN program focuses on translating research into practical solutions to combat the overdose crisis by increasing MOUD delivery and access for justice-involved populations. It supports a portfolio of hybrid effectiveness-implementation trials designed to dismantle barriers to evidence-based OUD treatments. This initiative is unique within HEAL for its dedicated focus on justice-involved individuals and criminal-legal systems, aiming to significantly reduce opioid-related harms.
Opportunity ID: 354743
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-25-061 |
Funding Opportunity Title: | HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 06, 2024 |
Last Updated Date: | Jun 06, 2024 |
Original Closing Date for Applications: | Jan 22, 2025 |
Current Closing Date for Applications: | Jan 22, 2025 |
Archive Date: | Feb 27, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education State governments Public housing authorities/Indian housing authorities Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Individuals in the US justice system are disproportionately likely to have SUD/OUD, are at high risk for opioid withdrawal upon incarceration, and are at elevated risk for overdose post-release if they have not received MOUD while detained. Most US jails do not offer MOUD to everyone who could benefit from them. JCOIN focuses on the translation of research-to-practice to address the overdose crisis in the context of the criminal justice system specifically, increasing delivery of and access to MOUD. A portfolio of research projects conducts hybrid effectiveness-implementation trials to address key barriers to delivery of evidence-based OUD treatments to justice-involved populations. This is the only HEAL initiative with a primary focus on justice-involved populations and criminal-legal systems. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-061.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 354743 Full Announcement-RFA-DA-25-061 -> RFA-DA-25-061-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or before January 24, 2025 | PKG00286878 | Dec 22, 2024 | Jan 24, 2025 | View |
Package 1
Mandatory forms
354743 RR_SF424_5_0-5.0.pdf
354743 PHS398_CoverPageSupplement_5_0-5.0.pdf
354743 RR_OtherProjectInfo_1_4-1.4.pdf
354743 PerformanceSite_4_0-4.0.pdf
354743 RR_KeyPersonExpanded_4_0-4.0.pdf
354743 RR_Budget_3_0-3.0.pdf
354743 PHS398_ResearchPlan_5_0-5.0.pdf
354743 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
354743 RR_SubawardBudget30_3_0-3.0.pdf
354743 PHS_AssignmentRequestForm_3_0-3.0.pdf